SMS Pharmaceuticals Limited (BOM:532815)

Market Cap	43.82B +74.1%
Revenue (ttm)	8.98B +10.2%
Net Income	1.02B +40.0%
EPS	11.04 +29.5%
Shares Out	n/a
PE Ratio	43.18
Forward PE	n/a
Dividend	0.40 (0.09%)
Ex-Dividend Date	Sep 22, 2026

Volume	10,704
Open	468.45
Previous Close	472.60
Day's Range	465.50 - 477.65
52-Week Range	262.05 - 494.40
Beta	n/a
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 6, 2026

About SMS Pharmaceuticals

SMS Pharmaceuticals Limited manufactures and sells active pharmaceutical ingredients (APIs) and its intermediates in India and internationally. It offers anti-retroviral, anti-inflammatory, anti-viral, anti-diabetic, anti-fungal, anti-epileptic, anti-migraine, anti-coagulant, anti-psychotic, anti-aginal, and anti-ulcer products. It is also involved in contract research activities on peptides. The company exports its products to approximately 75 countries. SMS Pharmaceuticals Limited was incorporated in 1987 and is headquartered in Hyderabad, In...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1987
• Employees: 1,617
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 532815

Financial Performance

In fiscal year 2026, SMS Pharmaceuticals's revenue was 8.89 billion, an increase of 13.53% compared to the previous year's 7.83 billion. Earnings were 1.02 billion, an increase of 47.52%.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Oct 7, 2026

Data Sources Report a data error